Fang Huiyu

Dr. Fang Huiyu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
FHFang Huiyu
Fang Huiyu
CHChi-Hsin Hsu
Chi-Hsin Hsu
CCChih-Hua Chao
Chih-Hua Chao
ZWZhi-Hong Wen
Zhi-Hong Wen
Yang-Chang WuYang-Chang Wu
Yang-Chang Wu
JSJyh-Horng Sheu
Jyh-Horng Sheu
Five new pregnane-type steroids, sclerosteroids J–N (1–5), and a diterpenoid with a new chemotype 3-methyl-5-(10′-acetoxy-2′,6′,10′-trimethylundecyl)-2-penten-5-olide (6), have been isolated from a soft coral Scleronephthya gracillimum. The structures of the metabolites were determined by extensive spectroscopic analysis. Compound 4 exhibited cytotoxicity against HepG2, A549, and MDA-MB-231 cancer cell lines. Furthermore, steroids 2 and 4 were found to significantly inhibit the accumulation of the pro-inflammatory iNOS protein, and 1, 2, 4 and 5 could effectively reduce the accumulation of COX-2 protein in LPS-stimulated RAW264.7 macrophage cells.

Verified
Journal Article
Open access
PDF file
FHFang Huiyu
Fang Huiyu
CUChokkalingam Uvarani
Chokkalingam Uvarani
SCShu Fen Chiou
Shu Fen Chiou
THTsong-Long Hwang
Tsong-Long Hwang
SCShu-Li Chen
Shu-Li Chen
JSJyh-Horng Sheu
Jyh-Horng Sheu
A new chromene derivative, 2-(4',8'-dimethylnona-3'E,7'-dienyl)-8-hydroxy-2,6-dimethyl-2H-chromene (1) together with four known natural products, methylfarnesylquinone (2), isololiolide (3), pheophytin a (4), and β-carotene (5) were isolated from the brown alga Homoeostrichus formosana. The structure of 1 was determined by extensive 1D and 2D spectroscopic analyses. Acetylation of 1 yielded the monoacetylated derivative 2-(4',8'-dimethylnona-3'E,7'-dienyl)-8-acetyl-2,6-dimethyl-2H-chromene (6). Compounds 1–6 exhibited various levels of cytotoxic, antibacterial, and anti-inflammatory activities. Compound 2 was found to display potent in vitro anti-inflammatory activity by inhibiting the generation of superoxide anion (IC50 0.22 ± 0.03 μg/mL) and elastase release (IC50 0.48 ± 0.11 μg/mL) in FMLP/CB-induced human neutrophils.